全文获取类型
收费全文 | 2015篇 |
免费 | 179篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 84篇 |
妇产科学 | 44篇 |
基础医学 | 223篇 |
口腔科学 | 39篇 |
临床医学 | 259篇 |
内科学 | 459篇 |
皮肤病学 | 24篇 |
神经病学 | 161篇 |
特种医学 | 266篇 |
外科学 | 184篇 |
综合类 | 43篇 |
一般理论 | 2篇 |
预防医学 | 163篇 |
眼科学 | 30篇 |
药学 | 157篇 |
中国医学 | 6篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 13篇 |
2021年 | 19篇 |
2020年 | 15篇 |
2019年 | 21篇 |
2018年 | 38篇 |
2017年 | 30篇 |
2016年 | 30篇 |
2015年 | 44篇 |
2014年 | 49篇 |
2013年 | 54篇 |
2012年 | 59篇 |
2011年 | 75篇 |
2010年 | 73篇 |
2009年 | 89篇 |
2008年 | 70篇 |
2007年 | 60篇 |
2006年 | 77篇 |
2005年 | 58篇 |
2004年 | 77篇 |
2003年 | 70篇 |
2002年 | 63篇 |
2001年 | 60篇 |
2000年 | 68篇 |
1999年 | 59篇 |
1998年 | 71篇 |
1997年 | 65篇 |
1996年 | 85篇 |
1995年 | 61篇 |
1994年 | 54篇 |
1993年 | 60篇 |
1992年 | 30篇 |
1991年 | 30篇 |
1990年 | 32篇 |
1989年 | 47篇 |
1988年 | 45篇 |
1987年 | 51篇 |
1986年 | 54篇 |
1985年 | 33篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 25篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 14篇 |
1976年 | 18篇 |
1975年 | 16篇 |
1974年 | 7篇 |
1973年 | 6篇 |
排序方式: 共有2202条查询结果,搜索用时 15 毫秒
1.
Betsy D. Kennard Susan G. Silva Simon Tonev Paul Rohde Jennifer L. Hughes Benedetto Vitiello Christopher J. Kratochvil John F. Curry Graham J. Emslie Mark Reinecke John March 《Journal of the American Academy of Child and Adolescent Psychiatry》2009,48(2):186-195
ObjectiveWe examine remission rate probabilities, recovery rates, and residual symptoms across 36 weeks in the Treatment for Adolescents with Depression Study (TADS).MethodThe TADS, a multisite clinical trial, randomized 439 adolescents with major depressive disorder to 12 weeks of treatment with fluoxetine, cognitive–behavioral therapy, their combination, or pill placebo. The pill placebo group, treated openly after week 12, was not included in the subsequent analyses. Treatment differences in remission rates and probabilities of remission over time are compared. Recovery rates in remitters at weeks 12 (acute phase remitters) and 18 (continuation phase remitters) are summarized. We also examined whether residual symptoms at the end of 12 weeks of acute treatment predicted later remission.ResultsAt week 36, the estimated remission rates for intention-to-treat cases were as follows: combination, 60%; fluoxetine, 55%; cognitive–behavioral therapy, 64%; and overall, 60%. Paired comparisons reveal that, at week 24, all active treatments converge on remission outcomes. The recovery rate at week 36 was 65% for acute phase remitters and 71% for continuation phase remitters, with no significant between-treatment differences in recovery rates. Residual symptoms at the end of acute treatment predicted failure to achieve remission at weeks 18 and 36.ConclusionsMost depressed adolescents in all three treatment modalities achieved remission at the end of 9 months of treatment. 相似文献
2.
3.
The use of Mixture Toxicity Indices (MTI's) is one of the more attractive approaches for describing and predicting the effects of mixtures of toxicants. For an MTI to apply to all possible mixtures of the compounds in question, it must summarize information from a model describing all possible responses of interest. A method of obtaining MTI's from response surface equations or from tolerance models similar to the toxic units model is presented. Methods of calculating several MTI's with desirable properties from multivariable probit response surfaces are demonstrated. 相似文献
4.
5.
6.
7.
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. 总被引:6,自引:3,他引:3 下载免费PDF全文
1. Male, Long Evans rats were chronically instrumented with pulsed Doppler flow probes and intravascular catheters to permit assessment of the regional haemodynamic responses to human and rat adrenomedullin, to compare the responses to human adrenomedullin to those of human alpha-CGRP in the absence and presence of the CGRP1-receptor antagonist, human alpha-CGRP [8-37], and to determine the involvement of nitric oxide (NO)-mediated mechanisms in the responses to human adrenomedullin, relative to human alpha-CGRP. 2. Human and rat adrenomedullin (0.3, 1, and 3 nmol kg-1, i.v.) caused dose-dependent hypotension and tachycardia, accompanied by increases in renal, mesenteric and hindquarters flows and vascular conductances. At the lowest dose only, the hypotensive and mesenteric vasodilator effects of rat adrenomedullin were significantly greater than those of human adrenomedullin. 3. Human alpha-CGRP at a dose of 1 nmol kg-1 caused hypotension, tachycardia and increases in hindquarters flow and vascular conductance, but reduction in renal and mesenteric flows, and only transient vasodilatations in these vascular beds. These effects were substantially inhibited by human alpha-CGRP [8-37] (100 nmol kg-1 min-1), but those of human adrenomedullin (1 nmol kg-1) were not; indeed, the mesenteric haemodynamic effects of the latter peptide were enhanced by the CGRP1-receptor antagonist. 4. In the presence of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 183 nmol kg-1 min-1), there was only a slight, but significant, inhibition of the hindquarters hyperaemic vasodilator effect of human adrenomedullin, but not that of human alpha-CGRP.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
8.
9.
10.